Loading patent…
AssigneeEvolva SA
InventorsThomas Oestergaard Tange, Johannes Haerle, Fanny Delegrange, Julien Denis Vivian De Block, Robert Charles Allan, Philipp Friedrich Berninger, Christophe Folly, Davide Antonio Ravasio, Ludivine Labagnere, Federico Brianza, Curt Aimé Friis Nielsen, Jørgen Hansen, Nora Weber, Samantha Jessica Capewell
Estimating the term…
The invention relates to recombinant microorganisms and methods of producing citronellal, citronellol, citronellic acid, and/or citronellal/citronellol pathway intermediates and precursors.
A recombinant host cell capable of producing a citronellal or a citronellic acid, comprising:
A recombinant host cell capable of producing a citronellal, a citronellol, or a citronellic acid, comprising:
A recombinant host cell capable of producing a citronellal, a citronellol, or a citronellic acid, comprising:
A recombinant host cell capable of producing a citronellal, a citronellol, or a citronellic acid, comprising:
A recombinant host cell capable of producing a citronellal and/or a citronellol, comprising:
A recombinant host cell capable of producing a citronellal, a citronellol, or a citronellic acid, comprising:
A method of producing a citronellal or a citronellol, comprising a whole-cell bioconversion of citronellal or citronellol precursors in a cell culture broth using one or more of:
A method of producing a citronellal or a citronellol, comprising:
Use of a GeDH polypeptide in the manufacture of geranial, citronellal, citronellol, citronellic acid, or a combination thereof.
Use of a NeDH polypeptide in the manufacture of neral, citronellal, citronellol, or citronellic acid or a combination thereof.
Use of a GeDH polypeptide and/or a NeDH polypeptide for the manufacture of geranial, neral, citronellal, citronellol, or citronellic acid or a combination thereof.
Use of a CiDH polypeptide in the manufacture of citronellal, citronellic acid or a combination thereof.
Use of a GeDH polypeptide in an in vitro or a whole-cell bioconversion manufacture of geranial, citronellal, citronellol, or citronellic acid or a combination thereof.
Use of a NeDH polypeptide in an in vitro or a whole-cell bioconversion manufacture of neral, citronellal, citronellol, or citronellic acid or a combination thereof.
Use of a GeDH polypeptide and a NeDH polypeptide in an in vitro or a whole-cell bioconversion manufacture of geranial, neral, citronellal, citronellol, or citronellic acid or a combination thereof.
Use of a CiDH polypeptide in an in vitro or a whole-cell bioconversion manufacture of citronellal, citronellic acid, or a combination thereof.
Use of a ENR polypeptide in the manufacture of citronellol, citronellal, citronellic acid, or a combination thereof.
Use of a ENR polypeptide in an in vitro or a whole-cell bioconversion manufacture of citronellol, citronellal, citronellic acid, or a combination thereof.
Use of a ISY polypeptide in the manufacture of citronellol, citronellal, citronellic acid or a combination thereof.
Use of a ISY polypeptide in an in vitro or a whole-cell bioconversion manufacture of citronellol, citronellal, citronellic acid, or a combination thereof.
Use of a AR polypeptide in the manufacture of geraniol, nerol, citronellol, citronellic acid or a combination thereof.
Use of a AR polypeptide in an in vitro or a whole-cell bioconversion manufacture of geraniol, nerol, citronellol, citronellic acid or a combination thereof.
Dependencies are inferred from the claim text.